Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kazakh Scientific Center of Dermatology and Infectious Diseases is a government-owned clinical, scientific, and public health institution under the Ministry of Health of Kazakhstan. The center was created in 2018 through the merger of the national AIDS prevention and control center with the skin and venereological research institute, and it provides prevention, diagnosis, treatment, epidemiologic monitoring, postgraduate education, and research services. Its core focus areas include HIV/AIDS, viral hepatitis, sexually transmitted infections, and dermatologic diseases, with both inpatient and consultative-diagnostic activities. The organization also conducts national and international research projects, including collaborations with UNAIDS, UNFPA, USAID, CDC, UNDP, and the Global Fund. It functions more like a specialized state medical and research center than a venture-backed biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kazakh Scientific Center of Dermatology and Infectious Diseases.